Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Phthalide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel process for cyanophthalide using sequential Grignard reagents offers safer, scalable route for antidepressant API manufacturing.
Patent CN1262549C details a novel hydrogenation route for 5-formylphthalide, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for antidepressant production.
Patent CN108794439B reveals a novel direct oxidation route for phthalide production, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN1423643A reveals a novel dehydration route for 5-cyanophthalide, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for antidepressant production.
Patent CN116253705A reveals a novel iron-catalyzed route for n-butylphthalide. This method offers mild conditions and cost reduction in pharmaceutical intermediate manufacturing.
Advanced synthesis of 5-cyano-2-benzo[c]furanone via amide dehydration. A cost-effective, high-yield route for Citalopram intermediates ensuring supply chain stability.
Novel lithium naphthalide cyclization method for high-purity benzogermanium pyrrole. Reduces noble metal use, enhances supply chain stability for electronic chemical manufacturing.
Advanced synthesis of high-purity butylphthalide via safe aqueous reduction and vacuum distillation. Ideal for reliable pharma intermediate supply chains.
Patent CN113004236B reveals a green POMs-catalyzed route for 3-methylenebenzofuran-1(3H)-ones, offering high yields and reduced costs for API manufacturing.
Discover a novel phthalide preparation method avoiding high-pressure hydrogenation. Ideal for agrochemical intermediates like kresoxim-methyl with reduced costs.
Patent CN114032258B reveals enzymatic route for L-butylphthalide intermediate. Offers high purity and cost efficiency for pharmaceutical supply chains.
Patent CN113200948A reveals a cost-effective copper-catalyzed route for chiral phthalides, offering high enantioselectivity and supply chain advantages for pharmaceutical manufacturers.
Patent CN103408520B details a high-yield arylation process for Alisertib intermediates, offering significant supply chain stability and cost reduction benefits for pharmaceutical manufacturers.
Patent CN1358176A reveals a novel synthesis for 2-heterocyclyl methyl benzoic acid derivatives, offering high purity and streamlined manufacturing for pharmaceutical intermediates.
Patent CN112778252A reveals a novel N-doped carbon bimetallic catalyst for converting o-xylene to phthalide with high selectivity, offering safer and cost-effective production.
Patent CN1331686A details a novel dehydration route for 5-cyanophthalide, offering superior yields and eliminating heavy metal catalysts for cost-effective API manufacturing.
Novel THF-based Grignard route ensures scalable production of anti-ischemia drug intermediates. Eliminates column chromatography for cost-effective supply chain solutions and high purity standards.
Advanced Raney Nickel catalyzed synthesis of butylphthalide eliminates high-energy rectification. Delivers >99% purity for reliable API intermediate supply chains.
Novel patent CN108623456A offers mild conditions for butylphthalide. Reduces cost and improves safety for reliable pharmaceutical intermediate supplier.
Novel Raney Nickel catalytic method reduces energy and solvent costs for pharmaceutical intermediate manufacturing supply chain efficiency and high purity output.